ABFM ITE In-Training Examination - Comprehensive Exam
Prep Document | 2026/2027 Edition | 150 Verified Questions -
140 Questions with Answers
ABFM ITE In-Training Examination 2026-140 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive preparation document for the American Board of Family Medicine In-Training
Examination (ABFM ITE) is meticulously curated for the 2026/2027 academic year. It features 150
verified questions with detailed rationales, covering all core domains of family medicine as specified
by the ABFM. Designed to mirror the actual exam's format and difficulty, this resource ensures a
thorough review of essential clinical knowledge, patient care, and preventive medicine. Each question
is accompanied by evidence-based explanations to reinforce learning and boost test-taking confidence.
Key Features:
Patient Care and Clinical Problem-Solving in Family Medicine
Medical Knowledge: Core Topics in Adult and Pediatric Medicine
Women's Health and Obstetrics
Men's Health and Urology
Geriatrics and Care of the Older Adult
Behavioral Health and Mental Health in Primary Care
Community Medicine, Population Health, and Epidemiology
Preventive Medicine and Health Maintenance
Diagnostic and Therapeutic Procedures in Family Medicine
Evidence-Based Medicine and Clinical Decision-Making
Ethical, Legal, and Professional Issues in Family Medicine
Healthcare Systems, Practice Management, and Quality Improvement
Dermatology in Primary Care
Musculoskeletal Medicine and Sports Medicine
Endocrinology and Metabolic Disorders
Cardiovascular Medicine in Primary Care
Pulmonary Medicine and Respiratory Care
Gastroenterology and Hepatology in Primary Care
Updates for 2026:
- Incorporate the latest ABFM ITE blueprint and content specifications for 2026-2027.
- Integrate updated clinical guidelines from AAFP, USPSTF, and other major medical societies.
- Add new questions on emerging public health issues and recent medical advancements.
- Revise rationales to reflect current evidence-based practice and diagnostic criteria.
- Enhance answer explanations with step-by-step clinical reasoning and distractor analysis.
Abstract:
This exam preparation document is an authoritative resource for candidates preparing for the ABFM In-Training
Examination (ITE) during the 2026-2027 academic year. It comprises 150 verified multiple-choice questions that
span the entire breadth of family medicine, including patient care, medical knowledge, and system-based practice.
Each question is meticulously crafted to reflect the style and complexity of the actual ITE, with detailed rationales
that explain not only the correct answer but also why the distractors are incorrect. The content is organized into
Page 1
,logical sections, each corresponding to a major domain of the ABFM curriculum, ensuring comprehensive
coverage. This document serves as an indispensable tool for residents and physicians seeking to assess their
knowledge, identify areas for improvement, and achieve a high score on the ITE. By integrating the latest
evidence-based guidelines and clinical recommendations, it ensures that users are up-to-date with current
standards of care. The inclusion of performance-tracking metrics and self-assessment aids further enhances its
utility as a study guide. Ultimately, this preparation document is designed to foster clinical competence and exam
readiness, empowering candidates to excel in their in-training assessment and future board certification.
Keywords:
ABFM ITE, Family Medicine In-Training Exam, Board Review, Clinical Knowledge, Patient Care, Preventive
Medicine, Evidence-Based Medicine, 2026-2027
Answer Format:
Each of the 150 questions is presented in a multiple-choice format with four or five options. Following each
question, a comprehensive rationale is provided that explains the correct answer in detail, referencing clinical
guidelines and evidence. Additionally, each distractor is analyzed to clarify why it is incorrect, reinforcing
understanding of the underlying concepts.
Compliance Checklist:
Aligned with the latest ABFM ITE content specifications and blueprint.
Includes 150 verified questions with accurate and up-to-date rationales.
Covers all major clinical domains and competencies required for the exam.
Reflects current guidelines from AAFP, USPSTF, and other authoritative bodies.
Designed to simulate the actual exam format and difficulty level.
Suitable for self-assessment and targeted study.
Content Area Overview:
Content Area Questions Key Topics Weight
Patient Care and Clinical 1-20 Diagnostic reasoning, management plans, 13%
Problem-Solving patient-centered care, clinical
decision-making
Medical Knowledge: Adult 21-50 Cardiovascular, pulmonary, endocrine, 20%
Medicine gastrointestinal, renal, hematology,
oncology
Medical Knowledge: Pediatrics 51-70 Growth and development, common pediatric 13%
illnesses, immunizations, adolescent health
Women's Health and Obstetrics 71-85 Prenatal care, contraception, menopause, 10%
breast health, gynecologic disorders
Men's Health and Urology 86-95 Prostate health, erectile dysfunction, 7%
testicular disorders, urinary tract infections
Geriatrics 96-105 Falls, dementia, polypharmacy, elder abuse, 7%
end-of-life care
Behavioral Health and Mental 106-115 Depression, anxiety, substance use 7%
Health disorders, ADHD, eating disorders
Community Medicine and 116-125 Epidemiology, biostatistics, health 7%
Population Health disparities, environmental health, public
health screening
Page 2
,Preventive Medicine and Health 126-135 Screening guidelines, immunizations, 7%
Maintenance counseling, risk assessment, preventive
interventions
Procedures and Diagnostic Tests 136-145 Common office procedures, interpretation of 7%
labs and imaging, ECG, spirometry
Evidence-Based Medicine and 146-150 Critical appraisal, clinical guidelines, ethics, 3%
Professionalism legal issues, practice management
Page 3
, Q1. A 56-year-old with type 2 diabetes and ASCVD risk equivalent is started on a
GLP-1 receptor agonist. Which additional therapy is most likely to reduce
cardiovascular mortality and is recommended as first-line add-on in current
guidelines?
A. SGLT2 inhibitor
B. DPP-4 inhibitor
C. Insulin glargine
D. Sulfonylurea
Correct Answer: A. SGLT2 inhibitor
Rationale: Current ADA/EASD guidelines recommend SGLT2 inhibitors or GLP-1 RAs
with proven cardiovascular benefit in patients with established ASCVD. Adding an SGLT2
inhibitor reduces cardiovascular mortality, heart failure hospitalization, and renal
progression. DPP-4 inhibitors, insulin, and sulfonylureas lack this mortality benefit.
Why Wrong:
B - DPP-4 inhibitors have a neutral effect on cardiovascular outcomes and are not
preferred for ASCVD risk reduction.
C - Insulin glargine has a neutral cardiovascular effect, not a mortality benefit.
D - Sulfonylureas are generally avoided in ASCVD due to potential adverse
cardiovascular effects and lack of benefit.
Reference: American Diabetes Association. Standards of Care in Diabetes-2026. Diabetes
Care. 2026;49(Suppl 1):S112-S136.
Q2. In a patient with newly diagnosed hypertension and stage 3 chronic kidney
disease, which medication class is most strongly associated with slowing renal
progression, and what is the preferred agent within that class?
A. ACE inhibitor; enalapril
B. ARB; losartan
C. Calcium channel blocker; amlodipine
D. Thiazide diuretic; chlorthalidone
Correct Answer: B. ARB; losartan
Rationale: In CKD with proteinuria, ARBs are preferred due to robust evidence (e.g.,
RENAAL, IDNT) showing renoprotection. Losartan specifically has demonstrated renal
benefits in type 2 diabetes with nephropathy. ACE inhibitors are also valid, but the
question asks for the most strongly associated and preferred agent, making ARB the best
answer.
Why Wrong:
A - ACE inhibitors are renoprotective but not specifically preferred over ARBs in
CKD; losartan has dedicated outcome data.
C - Amlodipine does not reduce proteinuria or slow renal progression as effectively as
Page 4
Prep Document | 2026/2027 Edition | 150 Verified Questions -
140 Questions with Answers
ABFM ITE In-Training Examination 2026-140 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive preparation document for the American Board of Family Medicine In-Training
Examination (ABFM ITE) is meticulously curated for the 2026/2027 academic year. It features 150
verified questions with detailed rationales, covering all core domains of family medicine as specified
by the ABFM. Designed to mirror the actual exam's format and difficulty, this resource ensures a
thorough review of essential clinical knowledge, patient care, and preventive medicine. Each question
is accompanied by evidence-based explanations to reinforce learning and boost test-taking confidence.
Key Features:
Patient Care and Clinical Problem-Solving in Family Medicine
Medical Knowledge: Core Topics in Adult and Pediatric Medicine
Women's Health and Obstetrics
Men's Health and Urology
Geriatrics and Care of the Older Adult
Behavioral Health and Mental Health in Primary Care
Community Medicine, Population Health, and Epidemiology
Preventive Medicine and Health Maintenance
Diagnostic and Therapeutic Procedures in Family Medicine
Evidence-Based Medicine and Clinical Decision-Making
Ethical, Legal, and Professional Issues in Family Medicine
Healthcare Systems, Practice Management, and Quality Improvement
Dermatology in Primary Care
Musculoskeletal Medicine and Sports Medicine
Endocrinology and Metabolic Disorders
Cardiovascular Medicine in Primary Care
Pulmonary Medicine and Respiratory Care
Gastroenterology and Hepatology in Primary Care
Updates for 2026:
- Incorporate the latest ABFM ITE blueprint and content specifications for 2026-2027.
- Integrate updated clinical guidelines from AAFP, USPSTF, and other major medical societies.
- Add new questions on emerging public health issues and recent medical advancements.
- Revise rationales to reflect current evidence-based practice and diagnostic criteria.
- Enhance answer explanations with step-by-step clinical reasoning and distractor analysis.
Abstract:
This exam preparation document is an authoritative resource for candidates preparing for the ABFM In-Training
Examination (ITE) during the 2026-2027 academic year. It comprises 150 verified multiple-choice questions that
span the entire breadth of family medicine, including patient care, medical knowledge, and system-based practice.
Each question is meticulously crafted to reflect the style and complexity of the actual ITE, with detailed rationales
that explain not only the correct answer but also why the distractors are incorrect. The content is organized into
Page 1
,logical sections, each corresponding to a major domain of the ABFM curriculum, ensuring comprehensive
coverage. This document serves as an indispensable tool for residents and physicians seeking to assess their
knowledge, identify areas for improvement, and achieve a high score on the ITE. By integrating the latest
evidence-based guidelines and clinical recommendations, it ensures that users are up-to-date with current
standards of care. The inclusion of performance-tracking metrics and self-assessment aids further enhances its
utility as a study guide. Ultimately, this preparation document is designed to foster clinical competence and exam
readiness, empowering candidates to excel in their in-training assessment and future board certification.
Keywords:
ABFM ITE, Family Medicine In-Training Exam, Board Review, Clinical Knowledge, Patient Care, Preventive
Medicine, Evidence-Based Medicine, 2026-2027
Answer Format:
Each of the 150 questions is presented in a multiple-choice format with four or five options. Following each
question, a comprehensive rationale is provided that explains the correct answer in detail, referencing clinical
guidelines and evidence. Additionally, each distractor is analyzed to clarify why it is incorrect, reinforcing
understanding of the underlying concepts.
Compliance Checklist:
Aligned with the latest ABFM ITE content specifications and blueprint.
Includes 150 verified questions with accurate and up-to-date rationales.
Covers all major clinical domains and competencies required for the exam.
Reflects current guidelines from AAFP, USPSTF, and other authoritative bodies.
Designed to simulate the actual exam format and difficulty level.
Suitable for self-assessment and targeted study.
Content Area Overview:
Content Area Questions Key Topics Weight
Patient Care and Clinical 1-20 Diagnostic reasoning, management plans, 13%
Problem-Solving patient-centered care, clinical
decision-making
Medical Knowledge: Adult 21-50 Cardiovascular, pulmonary, endocrine, 20%
Medicine gastrointestinal, renal, hematology,
oncology
Medical Knowledge: Pediatrics 51-70 Growth and development, common pediatric 13%
illnesses, immunizations, adolescent health
Women's Health and Obstetrics 71-85 Prenatal care, contraception, menopause, 10%
breast health, gynecologic disorders
Men's Health and Urology 86-95 Prostate health, erectile dysfunction, 7%
testicular disorders, urinary tract infections
Geriatrics 96-105 Falls, dementia, polypharmacy, elder abuse, 7%
end-of-life care
Behavioral Health and Mental 106-115 Depression, anxiety, substance use 7%
Health disorders, ADHD, eating disorders
Community Medicine and 116-125 Epidemiology, biostatistics, health 7%
Population Health disparities, environmental health, public
health screening
Page 2
,Preventive Medicine and Health 126-135 Screening guidelines, immunizations, 7%
Maintenance counseling, risk assessment, preventive
interventions
Procedures and Diagnostic Tests 136-145 Common office procedures, interpretation of 7%
labs and imaging, ECG, spirometry
Evidence-Based Medicine and 146-150 Critical appraisal, clinical guidelines, ethics, 3%
Professionalism legal issues, practice management
Page 3
, Q1. A 56-year-old with type 2 diabetes and ASCVD risk equivalent is started on a
GLP-1 receptor agonist. Which additional therapy is most likely to reduce
cardiovascular mortality and is recommended as first-line add-on in current
guidelines?
A. SGLT2 inhibitor
B. DPP-4 inhibitor
C. Insulin glargine
D. Sulfonylurea
Correct Answer: A. SGLT2 inhibitor
Rationale: Current ADA/EASD guidelines recommend SGLT2 inhibitors or GLP-1 RAs
with proven cardiovascular benefit in patients with established ASCVD. Adding an SGLT2
inhibitor reduces cardiovascular mortality, heart failure hospitalization, and renal
progression. DPP-4 inhibitors, insulin, and sulfonylureas lack this mortality benefit.
Why Wrong:
B - DPP-4 inhibitors have a neutral effect on cardiovascular outcomes and are not
preferred for ASCVD risk reduction.
C - Insulin glargine has a neutral cardiovascular effect, not a mortality benefit.
D - Sulfonylureas are generally avoided in ASCVD due to potential adverse
cardiovascular effects and lack of benefit.
Reference: American Diabetes Association. Standards of Care in Diabetes-2026. Diabetes
Care. 2026;49(Suppl 1):S112-S136.
Q2. In a patient with newly diagnosed hypertension and stage 3 chronic kidney
disease, which medication class is most strongly associated with slowing renal
progression, and what is the preferred agent within that class?
A. ACE inhibitor; enalapril
B. ARB; losartan
C. Calcium channel blocker; amlodipine
D. Thiazide diuretic; chlorthalidone
Correct Answer: B. ARB; losartan
Rationale: In CKD with proteinuria, ARBs are preferred due to robust evidence (e.g.,
RENAAL, IDNT) showing renoprotection. Losartan specifically has demonstrated renal
benefits in type 2 diabetes with nephropathy. ACE inhibitors are also valid, but the
question asks for the most strongly associated and preferred agent, making ARB the best
answer.
Why Wrong:
A - ACE inhibitors are renoprotective but not specifically preferred over ARBs in
CKD; losartan has dedicated outcome data.
C - Amlodipine does not reduce proteinuria or slow renal progression as effectively as
Page 4
